Kelly Brady
See Remarks at Seres Therapeutics, Inc. (MCRB)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $735
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 18SEC | MCRBSeres Therapeutics, Inc. | Sell Plan | 648,679 held (−1%) | $4.55 | $291 | -45.9% |
| May 19SEC | MCRBSeres Therapeutics, Inc. | Sell | 598,562 held (−1%) | $7.53 | $444 | -67.3% |
- Sell
See Remarks Kelly Brady sold $291 of MCRB at $4.55 — pre-scheduled 10b5-1 plan sale.